Skip to main content

SeaCrest Wealth Management, LLC

SEC CIK
0001728121
Latest filing
Jul 9, 2026

ABT holding history

Abbott Laboratories in every 13F filed by SeaCrest Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
4,349
Value
$394.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by SeaCrest Wealth Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,349$394.6K<0.1%−6,767−60.9%ReducedHolders
Q1 202611,116$1.14M0.1%+17+0.2%AddedHolders
Q4 202511,099$1.41M0.1%−423−3.7%ReducedHolders
Q3 202511,522$1.55M0.2%−474−4.0%ReducedHolders
Q2 202511,996$1.63M0.2%−2,189−15.4%ReducedHolders
Q1 202514,185$1.88M0.2%+83+0.6%AddedHolders
Q4 202414,102$1.60M0.2%+98+0.7%AddedHolders
Q3 202414,004$1.60M0.2%−186−1.3%ReducedHolders
Q2 202414,190$1.47M0.2%+204+1.5%AddedHolders
Q1 202413,986$1.59M0.2%−1,248−8.2%ReducedHolders
Q4 202315,234$1.69M0.2%−299−1.9%ReducedHolders
Q3 202315,533$1.50M0.2%−332−2.1%ReducedHolders
Q2 202315,865$1.73M0.2%+158+1.0%AddedHolders
Q1 202315,707$1.59M0.2%+238+1.5%AddedHolders
Q4 202215,469$1.70M0.2%−582−3.6%ReducedHolders
Q3 202216,051$1.55M0.2%−7,494−31.8%ReducedHolders
Q2 202223,545$2.56M0.3%−215−0.9%ReducedHolders
Q1 202223,760$2.81M0.3%−5,491−18.8%ReducedHolders
Q4 202129,251$4.12M0.5%+5,568+23.5%AddedHolders
Q3 202123,683$2.80M0.3%+2,576+12.2%AddedHolders
Q2 202121,107$2.45M0.3%−183−0.9%ReducedHolders
Q1 202121,290$2.55M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.